STOCKS TELEGRAPH

Tag: HCTI stock

  • Healthcare Triangle (HCTI) Stock Saw Rebound In Extended Session

    Healthcare Triangle (HCTI) Stock Saw Rebound In Extended Session

    Healthcare Triangle, Inc. (NASDAQ: HCTI) saw its shares rebound in after-hours trading on Friday following a key strategic development by its subsidiary. The stock climbed 11.58% in extended trading to $5.30, partially offsetting a steep regular-session decline of nearly 39%.

    Ezovion HIMS Debuts on Microsoft Azure Marketplace

    The surge followed Healthcare Triangle’s announcement that QuantumNexis, its wholly owned subsidiary, has launched the AI-powered Hospital Information Management System (HIMS), Ezovion, on Microsoft Azure Marketplace. The move boosts Ezovion’s global accessibility and positions HCTI for accelerated commercial expansion through a secure, enterprise-grade cloud platform.

    Ezovion is a cutting-edge, cloud-native HIMS made to digitize and optimize administrative, operational, and clinical processes. In order to reduce expenses, improve care delivery, and boost operational efficiency, the platform uses intelligent automation for everything from patient registration to invoicing, diagnostics, EMR integration, and mobile health services.

    Azure Integration Expands Reach and Scalability

    By joining the Microsoft Azure Marketplace, Ezovion Digital Healthcare Solutions gains exposure within a cloud ecosystem that transacts tens of billions of dollars annually. Consumers gain from improved productivity, cost reduction, and a safe online shopping experience.

    Global scalability, quicker go-to-market capabilities, and smooth implementation are other benefits of the Azure connection. Thanks to Microsoft’s safe cloud architecture, hospitals, clinics, and diagnostic centers may now use Ezovion with more confidence and dependability.

    International Growth Is Driven by Strategic Partnerships

    Healthcare Triangle’s AI-driven product portfolio, which includes GenAI-powered platforms like readable.ai for medical data automation and Ziloy for mental wellbeing, is still growing in accordance with its larger innovation plan.

    QuantumNexis is also developing strategic alliances in Malaysia, with expectations of generating a total potential income of about USD 2 million. With these efforts, HCTI is reaffirming its commitment to providing cutting-edge, AI-enabled healthcare solutions and expanding its worldwide footprint, especially in Southeast Asia.

    By making these calculated decisions, Healthcare Triangle establishes itself as a prominent, Nasdaq-listed leader in digital health, fostering innovation throughout the care spectrum and seizing fresh chances in international markets.

  • Healthcare Triangle Inc. (HCTI) stock Descends Further. What is happening?

    Healthcare Triangle Inc. (HCTI) stock Descends Further. What is happening?

    On January 20, Healthcare Triangle Inc. (HCTI) provided shareholders update in a press release. Following the update, the stock has been in a downtrend as investors seem unimpressed.

    During the previous regular trading session, the stock fluctuated between a high of $1.62 and a low of $1.48. HCTI closed the session with a loss of 2.25% at $1.52. The stock continued its decline into the after-hours to lose a further 7.89%. Consequently, the stock was trading at $1.40 apiece in the after hours.

    The healthcare information technology company, Healthcare Triangle Inc. has a market capitalization of $50.05 million. Currently, the company has 32.93 million shares outstanding in the market. Furthermore, HCTI stock has declined by 11.63% in the past five days, while losing 16.02% year to date.

    HCTI’s Shareholder Update

    On Thursday, the company provided its first shareholder update since its IPO in October 2021. The updates were provided in a letter to the shareholders from HCTI’s CEO and Chairman, Suresh Vekatachari.

    Some of the main highlights of the shareholder update include:

    • Recognition of HCTI as one of the top 100 premier partners of Amazon Web Services.
    • Premier Partner status with Google Cloud.
    • Appointment of Sanjay Dalwani as CRO for building a world-class sales team to help attain the company’s goal of being a top 10 U.S. healthcare IT provider by revenue, by 2025.
    • The strategic acquisition of DevCool Inc., an EPIC HER Implementation and Managed Services company.

    In addition, the company expects to keep growing as the Covid-19 pandemic along with its woes has also created some great opportunities. The pandemic has led the way for an unprecedented digital transformation, hence creating a huge array of opportunities. The global cloud revenue is expected to reach $474 billion in 2022, according to Gartner’s research. Further, the cloud services revenue is expected to grow exponentially over the next few years. Thus, the company plans to take full advantage of this and similar opportunities.

    Moreover, Mr. Vekatachari also applauded the HCTI team’s resilience and dedication in the face of the global pandemic.

    HCTI’s DataEz Platform

    DataEz is the company’s platform with digital and advanced analytics capabilities. It can provide the patient’s complete data in utmost detail including patient’s characteristics and behaviors’ effects on health outcomes, prediction of the disease progression, response to therapy, risk of adverse events, etc.

    Additionally, the DataEz platform can also help in applying an already approved drug to new used cases. Therefore, increasing the R&D investment’s efficiency and time to market.